Highlight recent updates in lung cancer management, both NSCLC and SCLC.Focus on translational approaches in understanding resistance biology to inform clinical management in patients treated with immuno and targeted therapiesProvide the latest update on understanding and use of biomarkers in the tumor macro and microenvironment and circulating in bloodFocus on changing concepts and use of immunotherapy and radiotherapy in lung cancer as well as in patients with CNS involvement